Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|June 29, 2001
Radiation therapy in the management of rectal cancerL A Kachnic, C G Willett
International Journal of Cancer|April 6, 2001
Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreasL A Kachnic, J E Shaw, M A Manning, et al.
Oncogene|April 17, 1997
Inactivation of p53 results in high rates of homologous recombinationK L Mekeel, W Tang, L A Kachnic, et al.
The Journal of Biological Chemistry|May 1, 1999
The ability of p53 to activate downstream genes p21(WAF1/cip1) and MDM2, and cell cycle arrest following DNA damage is delayed and attenuated in scid cells deficient in the DNA-dependent protein kinaseL A Kachnic, B Wu, H Wunsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Bladder preservation by combined modality therapy for invasive bladder cancerL A Kachnic, D S Kaufman, N M Heney, et al.
The Cancer Journal From Scientific American|March 1, 1996
Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patientL A Kachnic, W U Shipley, P P Griffin, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Results of a phase II trial of short-course radiation and TASOX [trifluridine/tipiracil (TAS-102) plus oxaliplatin] chemotherapy in operable rectal cancerH F Kennecke, J A Zell, H Pham, et al.
Prostate Cancer and Prostatic Diseases|October 2, 2013
RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patientsL A Kachnic, S L Pugh, P Tai, et al.
British Journal of Cancer|July 27, 2006
Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II studyA W Blackstock, F Mornex, C Partensky, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2000
Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservationD W Arthur, R K Schmidt-Ullrich, R B Friedman, et al.
Pageof 1